Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1980 1
1982 2
1983 1
1985 1
1986 1
1987 1
1988 2
1990 1
1991 1
1993 3
1994 3
1995 2
1996 1
1998 1
1999 3
2000 1
2001 1
2002 1
2003 2
2004 5
2005 3
2006 2
2007 2
2008 1
2009 1
2011 4
2012 3
2013 2
2014 5
2015 7
2016 3
2017 3
2018 2
2019 3
2020 5
2021 9
2022 5
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Non-Neoplastic Hematologic and Lymphocytic Disorder"
Page 1
Morphologic Characteristics of Myelodysplastic Syndromes.
Yuen LD, Hasserjian RP. Yuen LD, et al. Clin Lab Med. 2023 Dec;43(4):577-596. doi: 10.1016/j.cll.2023.06.003. Epub 2023 Aug 9. Clin Lab Med. 2023. PMID: 37865504 Review.
The presence of dysplasia is one of the key diagnostic criteria required for establishing a diagnosis of MDS, and the percentage of myeloblasts in the blood and bone marrow impacts both disease classification and prognostication. Morphologic features also aid in distinguis …
The presence of dysplasia is one of the key diagnostic criteria required for establishing a diagnosis of MDS, and the percentage of myelobla …
Significance of SF3B1 Mutations in Myeloid Neoplasms.
Gajzer DC, Yeung CCS. Gajzer DC, et al. Clin Lab Med. 2023 Dec;43(4):597-606. doi: 10.1016/j.cll.2023.07.005. Epub 2023 Sep 4. Clin Lab Med. 2023. PMID: 37865505 Review.
This article reviews the basic biology of SF3B1, iron metabolism, and dysfunction that leads to the formation of ring sideroblasts. It highlights neoplastic and non-neoplastic considerations to the differential diagnoses. Finally, a review on the evolution of the …
This article reviews the basic biology of SF3B1, iron metabolism, and dysfunction that leads to the formation of ring sideroblasts. It highl …
Distinguishing autoimmune myelofibrosis from primary myelofibrosis.
Marcellino B, El Jamal SM, Mascarenhas JO. Marcellino B, et al. Clin Adv Hematol Oncol. 2018 Sep;16(9):619-626. Clin Adv Hematol Oncol. 2018. PMID: 30256778 Review.
Bone marrow fibrosis (BMF) is a histologic finding in a wide range of diseases, including malignancies, endocrine disorders, autoimmune diseases, and infections. Autoimmune myelofibrosis (AIMF) is an uncommon etiology of BMF; it can be secondary to a defined autoimm …
Bone marrow fibrosis (BMF) is a histologic finding in a wide range of diseases, including malignancies, endocrine disorders, autoimmu …
Lymphocyte migration and retention properties affected by ibrutinib in chronic lymphocytic leukemia.
Rey-Barroso J, Munaretto A, Rouquié N, Mougel A, Chassan M, Gadat S, Dewingle O, Poincloux R, Cadot S, Ysebaert L, Quillet-Mary A, Dupré L. Rey-Barroso J, et al. Haematologica. 2024 Mar 1;109(3):809-823. doi: 10.3324/haematol.2022.282466. Haematologica. 2024. PMID: 37381758 Free PMC article.
In vitro, ibrutinib affected CCL19-, CXCL12- and CXCL13-evoked migration behavior of CLL cells and non-neoplastic lymphocytes, by reducing both motility speed and directionality. ...Remarkably, the relative expression of the receptors governing lymph node entry (CCR …
In vitro, ibrutinib affected CCL19-, CXCL12- and CXCL13-evoked migration behavior of CLL cells and non-neoplastic lymphocytes, …
Acute lymphoblastic leukemia and lymphoma in the context of constitutional mismatch repair deficiency syndrome.
Ripperger T, Schlegelberger B. Ripperger T, et al. Eur J Med Genet. 2016 Mar;59(3):133-42. doi: 10.1016/j.ejmg.2015.12.014. Epub 2015 Dec 30. Eur J Med Genet. 2016. PMID: 26743104 Review.
Constitutional mismatch repair deficiency (CMMRD) syndrome is one of the rare diseases associated with a high risk of cancer. Causative mutations are found in DNA mismatch repair genes PMS2, MSH6, MSH2 or MLH1 that are well known in the context of Lynch syndrome. ...T-cell …
Constitutional mismatch repair deficiency (CMMRD) syndrome is one of the rare diseases associated with a high risk of cancer. Causati …
Autoimmune myelofibrosis: an update on morphologic features in 29 cases and review of the literature.
Vergara-Lluri ME, Piatek CI, Pullarkat V, Siddiqi IN, O'Connell C, Feinstein DI, Brynes RK. Vergara-Lluri ME, et al. Hum Pathol. 2014 Nov;45(11):2183-91. doi: 10.1016/j.humpath.2014.07.017. Epub 2014 Aug 13. Hum Pathol. 2014. PMID: 25282037 Review.
Autoimmune myelofibrosis (AIMF) is a distinct clinicopathological entity associated with diffuse bone marrow fibrosis and a benign clinical course. Distinction from neoplastic etiologies of marrow fibrosis, particularly primary myelofibrosis, is imperative, but few studies …
Autoimmune myelofibrosis (AIMF) is a distinct clinicopathological entity associated with diffuse bone marrow fibrosis and a benign clinical …
Role of in-phase and out-of-phase chemical shift MRI in differentiation of non-neoplastic versus neoplastic benign and malignant marrow lesions.
van Vucht N, Santiago R, Pressney I, Saifuddin A. van Vucht N, et al. Br J Radiol. 2021 Mar 1;94(1119):20200710. doi: 10.1259/bjr.20200710. Epub 2021 Feb 17. Br J Radiol. 2021. PMID: 33571012 Free PMC article.
OBJECTIVE: To determine its ability of in-phase (IP) and out-of-phase (OOP) chemical shift imaging (CSI) to distinguish non-neoplastic marrow lesions, benign bone tumours and malignant bone tumours. ...CONCLUSION: CSI is accurate for differentiating non-ne …
OBJECTIVE: To determine its ability of in-phase (IP) and out-of-phase (OOP) chemical shift imaging (CSI) to distinguish non-neopla …
MicroRNAs and exosomes: promising new biomarkers in acute myeloid leukemias?
Araújo HV, Sakamoto LHT, Bacal NS, Epelman S, Real JM. Araújo HV, et al. Einstein (Sao Paulo). 2022 Mar 7;20:eRB5954. doi: 10.31744/einstein_journal/2022RB5954. eCollection 2022. Einstein (Sao Paulo). 2022. PMID: 35303052 Free PMC article.
Despite advances in understanding of carcinogenesis and of treatment of acute myeloid leukemia, this neoplasm still has a lethality of at least 30%. The search for biomarkers that can predict the response to treatment in the early stages of the disease is still necessary. …
Despite advances in understanding of carcinogenesis and of treatment of acute myeloid leukemia, this neoplasm still has a lethality of at le …
Clinicopathological significance of CD28 overexpression in adult T-cell leukemia/lymphoma.
Sakamoto Y, Ishida T, Masaki A, Takeshita M, Iwasaki H, Yonekura K, Tashiro Y, Ito A, Kusumoto S, Iida S, Utsunomiya A, Ueda R, Inagaki H. Sakamoto Y, et al. Cancer Sci. 2022 Jan;113(1):349-361. doi: 10.1111/cas.15191. Epub 2021 Nov 29. Cancer Sci. 2022. PMID: 34738707 Free PMC article.
Compared with non-overexpressers, CD28 overexpressers showed a higher frequency of CD28 genetic alterations and had an increased number of CD80/CD86-positive non-neoplastic cells infiltrating tumor microenvironment. In the entire ATLL patient cohort, CD28 overexpres …
Compared with non-overexpressers, CD28 overexpressers showed a higher frequency of CD28 genetic alterations and had an increased number of C …
Prevalence of p53 dysregulations in feline oral squamous cell carcinoma and non-neoplastic oral mucosa.
Renzi A, De Bonis P, Morandi L, Lenzi J, Tinto D, Rigillo A, Bettini G, Bellei E, Sabattini S. Renzi A, et al. PLoS One. 2019 Apr 18;14(4):e0215621. doi: 10.1371/journal.pone.0215621. eCollection 2019. PLoS One. 2019. PMID: 30998743 Free PMC article.
Additionally, the prevalence of p53 dysregulation in feline oral squamous cell carcinoma was compared with that of feline non-neoplastic oral mucosa, in order to investigate the relevance of these dysregulations in cancer development. ...The agreement between immuno …
Additionally, the prevalence of p53 dysregulation in feline oral squamous cell carcinoma was compared with that of feline non-neop …
95 results